Dana Investment Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Dana Investment Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,007	Closed	-$558K	–	365
2021 Q4	$558K	Buy	6,007 +14	+0.2%	+$922	0.02%	256
2021 Q3	$357K	Buy	+5,993	New	+$354K	0.02%	272

Dana Investment Advisors's ARNA Position: Q1 2022 in Review

Dana Investment Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 6,007 shares — an estimated $558K sold.

Dana Investment Advisors first reported a position in ARNA in Q3 2021 and held it in 2 quarters. The position peaked at $558K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Dana Investment Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Dana Investment Advisors sold 6,007 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $558K.
Dana Investment Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2021 and held it in 2 quarters.
Dana Investment Advisors's Arena Pharmaceuticals Inc position peaked at $558K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Dana Investment Advisors's 13F filing for Q1 2022, filed 12 May 2022.